Joseph W. Vazzano's most recent trade in Abeona Therapeutics Inc was a trade of 17,795 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 06 Jun 2025 | 17,795 | 491,246 (0%) | 0% | 6.8 | 120,294 | Common Stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 13,333 | 504,579 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 14 Mar 2025 | 685 | 509,041 (0%) | 0% | 5.3 | 3,624 | Common stock |
| Allarity Therapeutics Inc | Joseph W. Vazzano | Director | 22 Jan 2025 | 25,000 | 25,000 | - | - | Stock Options | ||
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 144,509 | 509,726 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.89 per share. | 28 Sep 2024 | 6,388 | 365,217 (0%) | 0% | 5.9 | 37,625 | Common stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.11 per share. | 21 Jul 2024 | 1,055 | 371,605 (0%) | 0% | 5.1 | 5,391 | Common stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 155,200 | 372,660 (0%) | 0% | 0 | Common stock |